Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

In October, when GSK agreed to a $2.2 billion settlement to resolve approximately 80,000 lawsuits | With a $2.2 billion ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

LEONARDO MUNOZ/AFP via Getty Images. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy ...

GSK was forced to pay around £1.8bn to settle thousands of cases in US courts in October amid claims Zantac caused cancer. Pharmaceutical giant GSK has hiked its 2031 sales forecast to more than £40bn ...

Alongside the share buyback, GSK reported growth in annual revenue, but a decline in profit, with its bottom line hurt by a Zantac litigation settlement charge. In response, shares in GSK were up 5.9% ...

Operating profits dropped by 40% to £4 billion due to a £1.8 billion settlement following lawsuits linked to its former heartburn drug Zantac. GSK said it expects core operating profits to rise ...

Operating profits dropped by 40% to £4 billion due to a £1.8 billion settlement following lawsuits linked to its former heartburn drug Zantac. GSK said it expects core operating profits to rise by ...

British pharmaceutical group GSK on Wednesday reported a near halving of net profit in 2024 after settling hefty US lawsuits over its Zantac heartburn drug. The company upgraded its outlook, however, ...

who did not know that GSK had for decades concealed an internal study that implicated the Company's liability to Zantac users. The truth began to emerge on August 10, 2022, when a Deutsche Bank ...